Brivaracetam is an antiepileptic API supplied as a crystalline powder for pharmaceutical use. It is used in formulations intended for the treatment of partial-onset (focal) seizures in patients with epilepsy. The API is handled under controlled conditions to ensure consistent quality. Pharma-grade packaging is employed to protect against environmental factors. Appropriate storage conditions help maintain stability throughout the product lifecycle.
As a leading distribution partner, Molkem Chemicals supports the reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications and is supported by standard documentation, including COA, SDS, and TDS. Where required, additional stability data and regulatory assistance can be extended through our technical team.
Global - English
Brazil - Portuguese
Thailand - Thai
Middle East - Arabic
Vietnam - Vietnamese
Spain - Spanish
Colombia - Spanish
Argentina - Spanish
